Stem cell therapy of cataract

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Stem Cell Biology

Background:

• Cataract is a leading cause of blindness globally, with surgery as the only current treatment.
• Alternative therapies are needed to address the significant burden of cataract.
• Stem cell therapy offers a potential alternative treatment modality for cataracts.

Purpose of the Study:

• To investigate the potential of Wharton's jelly derived stem cells (hWJSCs) as a novel source for cataract treatment.
• To evaluate the ability of hWJSCs to restore lens structure and function.

Main Methods:

• Cataract was induced in an animal model, and the lens was removed.
• Human Wharton's jelly stem cells (hWJSCs) were injected into the empty lens capsule.
• Expression of crystallin proteins and visual function were analyzed post-injection.

Main Results:

• The lens capsule served as a natural scaffold for cell engraftment.
• Injected hWJSCs demonstrated potential for differentiation into lens fiber cells.
• Restoration of lens structure and potential improvement in vision were observed.

Conclusions:

• The lens capsule can function as a natural scaffold for stem cell integration.
• hWJSCs hold promise for regenerating lens structures and treating cataracts.
• This approach offers a potential alternative to traditional cataract surgery.